Pro-Dex Inc New (PDEX) — Analysis Summary
Pro-Dex Inc New (PDEX) has a market cap of $196.51M with year-over-year revenue growth of +23.7%. Net margin stands at 13.5%. The stock trades at a P/E ratio of 16.4.
Key Takeaways
- Revenue changed +23.7% year-over-year
- Net margin of 13.5%
- P/E ratio of 16.4
Compared to other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, PDEX posted revenue growth of +23.7% and trades at a P/E of 16.4.
Pro-Dex Inc New (PDEX)
UPDATED — ET · SOURCE POLYGON
Red Flags & WarningsNo Major Flags
No major credit, margin, or trend red flags were triggered from the latest filings.
Pro-Dex Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers (OEMs) to various countries. Its product portfolio includes autoclavable, battery-powered, electric, and multi-function surgical drivers and shavers used mainly in orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, regulatory consulting services, and manufactures rotary air motors utilized in various industries. Operating out of ISO-certified facilities in California, Pro-Dex serves hospitals, medical labs, and high-tech manufacturers, generating revenue through sales of surgical instruments and related services.
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees
181
Headquarters
IRVINE, CA
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.